New regulatory changes in pharma manufacturing, the demand for personalized medicines, new treatment options and innovative approaches in prevention and diagnostics are among the key challenges facing the pharmaceutical industry. These seismic shifts offer opportunities not only for traditional pharmaceutical providers, but also for technology companies from outside the sector. Over and above fulfilment of the industry’s stringent regulations, approvals and certification requirements, factors such as process reliability and flexibility play decisive roles.
With impressive levels of flexibility, robotbased automation solutions are the first choice for small batch production runs in personalized medicine. They offer the additional advantage of reducing human contact to a minimum, and thereby avoiding the risk of contamination.
Stäubli has been a partner to the pharmaceutical industry for decades, responsible for pioneering developments such as our acclaimed Stericlean models, which facilitate automation in aseptic environments. More recently, we have worked in close partnership with OEMs and integrators to expand our robotics portfolio for pharmaceutical applications. We continue to collaborate intensively on further developments which will enable us to offer digitally networked and other automation solutions for just about any conceivable future production scenario.
Working in collaboration with industry players over the years, Stäubli has amassed substantial know-how. This benefits our customers in the planning of every new project, including systems and assembly lines for the production of APIs and biotherapeutics; industry-scale filling and packaging of liquid, powder and solid medicines; loading/unloading systems for freeze dryers, autoclaves, parts washer etc.; and production of packaging materials and automated processes in laboratories and pharmacies. Our wealth of experience and range of robots make Stäubli an automation specialist you can rely on.